Live Breaking News & Updates on Myrisk hereditary cancer test
Stay updated with breaking news from Myrisk hereditary cancer test. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Federated Hermes Inc. decreased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 55,009 shares of the company’s stock after selling 1,533 shares during the quarter. […]
Myriad Genetics, Inc. (NASDAQ:MYGN) Given Consensus Rating of "Hold" by Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have received an average recommendation of “Hold” from the six analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation and three have assigned a buy recommendation to the company. […]
Shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) have been given an average rating of “Hold” by the six brokerages that are covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to […]
China Universal Asset Management Co. Ltd. raised its holdings in Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 388.0% during the fourth quarter, HoldingsChannel.com reports. The firm owned 10,253 shares of the company’s stock after buying an additional 8,152 shares during the period. China Universal Asset Management Co. Ltd.’s holdings in Myriad Genetics were worth […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.03, Briefing.com reports. The business had revenue of $196.60 million for the quarter, compared to analysts’ expectations of $194.80 million. Myriad Genetics had […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) issued an update on its FY 2024 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 0.000-0.050 for the period, compared to the consensus estimate of -0.010. The company issued revenue guidance of $820.0 million-$840.0 million, compared to the consensus revenue estimate of […]
Profund Advisors LLC decreased its holdings in shares of Myriad Genetics, Inc. (NASDAQ:MYGN – Free Report) by 2.7% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,839 shares of the company’s stock after selling 1,086 shares during the period. Profund Advisors LLC’s […]
Myriad Genetics (NASDAQ:MYGN) Updates FY24 Earnings Guidance theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Myriad Genetics (NASDAQ:MYGN) Issues FY24 Earnings Guidance themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.